Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… glioma, borderline personality disorder, and colorectal cancer. He has experience in clinical trial monitoring, regulatory review, data management, Food and Drug Administration regulation and International …
… Nurse Specialist University of Texas M.D. Anderson Cancer Center, Houston, TX Lia Gutiérrez, MPH, BSc, is a … analysis and reporting of regulatory observational drug safety studies involving different data collection … research positions at the University of Texas MD Anderson Cancer Center in Houston and worked as a …
Benefit-Risk Assessment Do your product’s benefits outweigh its potential risks? More importantly, do you have the right data to credibly demonstrate this to regulators, payers, physicians, and patients? You can rely on our experienced team to help you …
… for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data … for rare disease research that can help you gain orphan drug reimbursement. View this webinar where you’ll learn: …
… Best Practices for Interacting with ICER A systematic review of ICER evaluations from 2008 to 2018: recent trends … DM Transcript: The Institute for Clinical and Economic Review, or ICER, is an independent, non-partisan research … responses from ICER as well. We found that the ICER review process has become more transparent and collaborative. …
… perspectives did you bring to the Task Force? A: I review a lot of journal articles both as an associate editor … for sure. I believe that authors will get through the peer-review process more quickly if they have followed the … guidelines. Some editors might decide not to send it for review unless the authors have completed the checklist. As an …
… Therapeutic Experience Explore our Projects, Publications, and Researchers by Therapeutic Area To help … context. We've conducted over 6,600 projects-- spanning drug development, commercialization, and safety --across all …
… support to clients related to negotiations with the Food and Drug Administration (FDA), including development of COA … , Annals of Behavioral Medicine, Clinical Therapeutics , Drug and Therapy Perspectives, Health Psychology, …
… to tackle societal and operational problems in healthcare. Cancer Screening Policies In Chapter 7, Optimization of Biomarker-Based Prostate Cancer Screening Policies, coauthor Dr. Barnett discusses cancer screening, which has the potential to improve patient …
… patient and site recruitment, development of institutional review board materials). In addition, she has a broad range … reports, and regulatory documents for submission to the Food and Drug Administration. Additionally, she has experience …